Q1 2020 13F Holders as of 31 Mar 2020
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
13,080,549
-
Total 13F shares
-
13,275,863
-
Share change
-
+24,439
-
Total reported value
-
$611,072,914
-
Put/Call ratio
-
144%
-
Price per share
-
$46.00
-
Number of holders
-
165
-
Value change
-
-$10,250,719
-
Number of buys
-
74
-
Number of sells
-
83
Institutional Holders of EAGLE PHARMACEUTICALS, INC. - Common Stock (EGRX) as of Q1 2020
As of 31 Mar 2020 EAGLE PHARMACEUTICALS, INC. - Common Stock (EGRX) had 165 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 13,275,863 shares of stock of the company.
Largest 10 holders included JANUS HENDERSON GROUP PLC, BlackRock Inc., Park West Asset Management LLC, VANGUARD GROUP INC, STATE STREET CORP, CREDIT SUISSE AG/, GOLDMAN SACHS GROUP INC, Invesco Ltd., LSV ASSET MANAGEMENT, and DIMENSIONAL FUND ADVISORS LP.
This table shows 165 institutional shareholders of the security as of 31 Mar 2020.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.